10-Q: Longduoduo Reports Steep Revenue Decline, Net Loss in Q2

Longduoduo Company Limited reported a significant decrease in revenue and a shift to net loss for the three and six months ended December 31, 2025, citing a challenging economic environment in China.

Summary

• Total revenue for the three months ended December 31, 2025, decreased by 81% to $345,265 from $1,775,495 in the prior year period.
• Total revenue for the six months ended December 31, 2025, decreased by 61% to $1,004,029 from $2,544,567 in the prior year period.
• The company reported a net loss of $274,245 for the three months ended December 31, 2025, compared to a net income of $501,599 in the same period last year.
• A net loss of $385,427 was recorded for the six months ended December 31, 2025, a significant decline from a net income of $442,095 in the corresponding prior year period.
• Gross profit fell by 81% for the three-month period and 60% for the six-month period, primarily due to reduced service and commission revenue.
• Operating expenses decreased by 46% for the three-month period and 30% for the six-month period, mainly driven by lower advertising and promotion expenses.
• Net cash used in operating activities for the six months ended December 31, 2025, was $105,572, a reversal from $280,261 provided by operating activities in the prior year.
• The company's working capital was $634,590 as of December 31, 2025, with deferred revenue of $684,337 largely used to fund operations.
• One customer accounted for 99.0% of revenue for the six months ended December 31, 2025, indicating high customer concentration risk.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing with a highly negative sentiment due to the drastic decline in revenue, a significant shift to net losses, negative operating cash flow, and explicit concerns about the company's ability to continue as a going concern, compounded by material weaknesses in internal controls.

Positives

• Operating expenses decreased by $524,953 (46%) for the three months and $587,357 (30%) for the six months ended December 31, 2025, primarily due to reduced advertising, salaries, and professional fees.
• Net cash used in investing activities decreased to $30,088 for the six months ended December 31, 2025, from $56,306 in the prior year, indicating lower capital expenditures.

Negatives

• Total revenue decreased by 81% for the three months and 61% for the six months ended December 31, 2025, primarily due to a decline in both service and commission revenue.
• The company shifted from a net income of $501,599 to a net loss of $274,245 for the three months ended December 31, 2025.
• The company shifted from a net income of $442,095 to a net loss of $385,427 for the six months ended December 31, 2025.
• Gross profit from service revenue turned negative, with a gross loss of $1,168 (-28% margin) for the three months and $2,272 (-23% margin) for the six months ended December 31, 2025.
• Net cash flow from operating activities turned negative, using $105,572 for the six months ended December 31, 2025, compared to providing $280,261 in the prior year.
• Total stockholders' equity decreased from $1,296,032 at June 30, 2025, to $957,925 at December 31, 2025.

Risks

• The prevailing economic environment in China, characterized by waning confidence, has led to cautious consumer spending and curtailed discretionary expenditures, negatively impacting revenue.
• The company faces significant customer concentration risk, with one customer accounting for 99.0% of revenue for the six months ended December 31, 2025.
• There are material weaknesses in internal control over financial reporting, including a small number of accounting employees preventing segregation of duties, lack of U.S. GAAP expertise among internal financial staff, the CFO's unfamiliarity with U.S. public company accounting requirements, and insufficient documentation of financial processes.
• The company's ability to continue as a going concern is uncertain, as there are no assurances it can generate sufficient cash flows from operations or obtain additional financing.
• Changes in U.S. and China relations, including potential new legislation, executive orders, tariffs, sanctions, or increased SEC scrutiny, may adversely impact the business, operating results, ability to raise capital, and share price.
• A significant portion of the company's cash ($967,851 as of December 31, 2025) is held in state-owned banks in China, exceeding the RMB500,000 (approximately $71,000) insurance coverage per account, exposing it to credit risk.

Future Outlook

Management believes that while the government has introduced policies to promote economic recovery, it may take time for the situation to truly improve. The company plans to continue investing heavily in advertising and promotion expenses in the near future to establish and expand its brand and services. There are no assurances that the company will generate sufficient cash flows or obtain additional financing to remain a going concern.

Management Comments

• "The prevailing economic environment, characterized by waning confidence in economic prospects, has compelled consumers to adopt significantly more cautious spending behavior, curtailing discretionary expenditures."
• "Management believes that the government has recently introduced policies to promote economic recovery, but it may take some time for the situation to truly improve."
• "Meanwhile, as we wait for the economy to revive, the Company is implementing plans to improve its operations by adjusting its operational policies."
• "The Company will continue to invest heavily in advertising and promotion expenses in the near future as it continues to establish and expand its brand and products and services."
• "We anticipate that our future liquidity requirements will arise from the need to fund our growth, pay current obligations and future capital expenditures."
• "We expect Zhang Liang, our majority shareholder, to continue to provide support in the future, if needed."

Industry Context

StockSavvy.ai notes that Longduoduo's significant revenue decline and shift to net loss reflect broader challenges within the Chinese consumer discretionary and healthcare sectors, particularly as economic uncertainties lead to reduced non-essential spending. The company's reliance on a single major customer also highlights a vulnerability not uncommon in developing markets but amplified by current economic headwinds. The stated intent to continue heavy marketing investment, despite current losses, suggests a long-term brand-building strategy, but its effectiveness will depend on a broader economic recovery and the company's ability to manage its liquidity.

Comparison to Industry Standards

• The filing does not provide specific comparable companies or industry benchmarks to assess Longduoduo's performance against global standards. However, the reported gross loss from service revenue (-28% for Q2 2025) is significantly below typical healthy margins for healthcare service providers, which often range from 20-50% or higher, indicating severe operational inefficiencies or pricing pressures.
• The high customer concentration (99% from one customer) is a critical deviation from industry best practices for diversified healthcare or service companies, which typically aim for a more balanced customer portfolio to mitigate revenue risk.
• The identified material weaknesses in internal controls, particularly regarding U.S. GAAP expertise and segregation of duties, suggest a governance framework that falls short of the robust standards expected of publicly traded companies, especially when compared to established global peers in the healthcare sector.

Corporate Governance

Related Party Transactions

• As of December 31, 2025, $306 was due from Zhou Hongxiao, the CEO, which is unsecured, repayable on demand, and bears no interest.
• As of December 31, 2025, $409 was due to Zhang Liang, the majority shareholder, which is unsecured, repayable on demand, and bears no interest.
• As of December 31, 2025, $1,072 was due to Xu Huibo, the President and Chairman, which is unsecured, repayable on demand, and bears no interest.

Stakeholder Impact

• Shareholders: Significant negative impact due to substantial revenue decline, net losses, negative operating cash flow, and concerns about the company's going concern status, likely leading to decreased share value.
• Employees: Potential impact on job security or compensation given the company's financial performance and operational adjustments.
• Customers: Potential impact on service quality or availability if financial difficulties persist, although the company is adjusting operational policies.
• Creditors: Increased risk due to the company's liquidity concerns and the explicit statement about no assurances of generating sufficient cash flows to remain a going concern.
• Suppliers: Potential impact on payment terms or future business relationships due to the company's financial health and high concentration of accounts payable to a few major suppliers.

Next Steps

• The company is implementing plans to improve its operations by adjusting operational policies.
• The company will continue to invest heavily in advertising and promotion expenses in the near future to establish and expand its brand and products and services.
• The company expects to seek additional funds from a public offering and/or debt financing to support growth and capital expenditures.

Key Dates

Recommendation

The company's financial performance is severely deteriorating, marked by an 81% decline in quarterly revenue, a shift from net income to substantial net losses, and negative cash flow from operations. Management explicitly states there are no assurances the company can generate sufficient cash flows to remain a going concern, and significant material weaknesses in internal controls further undermine confidence. The high customer concentration and geopolitical risks add to the precarious outlook. These factors collectively indicate a high probability of continued financial distress and significant downside risk for investors.

Keywords

Healthcare services, Commission revenue, China economy, SEC filing, 10-Q, Financial results, Operating loss, Net loss, Internal controls, U.S.-China relations, Preventive healthcare